share_log

Novo Integrated Sciences | 8-K: Current report

Novo Integrated Sciences | 8-K: Current report

Novo Integrated Sciences | 8-K:重大事件
美股sec公告 ·  06/13 16:35
Moomoo AI 已提取核心訊息
On June 13, 2024, Novo Integrated Sciences, Inc. announced the receipt of a Standby Letter of Credit (SBLC) issued by HSBC, which is set to be delivered via Swift MT760. This development is part of a monetizing program that the company had previously applied for, with the expectation of receiving approximately $78 million in gross funding proceeds upon the completion of the SBLC's monetization. The funds are intended to facilitate the acquisition of the Ophir Collection, granting Novo Integrated Sciences sole ownership of the collection. Additionally, the proceeds are expected to support the company's share repurchase program. CEO and Board Chairman Robert Mattacchione expressed enthusiasm for the progress towards the acquisition and the company's commitment to raising non-dilutive capital. Novo Integrated Sciences, which is pioneering a holistic approach to healthcare through a multidisciplinary ecosystem, plans to use advanced medical technology and rehabilitative science to decentralize non-catastrophic healthcare delivery.
On June 13, 2024, Novo Integrated Sciences, Inc. announced the receipt of a Standby Letter of Credit (SBLC) issued by HSBC, which is set to be delivered via Swift MT760. This development is part of a monetizing program that the company had previously applied for, with the expectation of receiving approximately $78 million in gross funding proceeds upon the completion of the SBLC's monetization. The funds are intended to facilitate the acquisition of the Ophir Collection, granting Novo Integrated Sciences sole ownership of the collection. Additionally, the proceeds are expected to support the company's share repurchase program. CEO and Board Chairman Robert Mattacchione expressed enthusiasm for the progress towards the acquisition and the company's commitment to raising non-dilutive capital. Novo Integrated Sciences, which is pioneering a holistic approach to healthcare through a multidisciplinary ecosystem, plans to use advanced medical technology and rehabilitative science to decentralize non-catastrophic healthcare delivery.
2024年6月13日,Novo Integrated Sciences,Inc.宣佈收到了匯豐銀行發行的備用信用證(SBLC),將通過Swift MT760交付。該發展計劃是該公司先前申請的貨幣化計劃的一部分,預計在完成SBLC的貨幣化後可獲得約7800萬美元的總資金籌集收益。這些資金旨在促進Ophir Collection的收購,授予Novo Integrated Sciences收藏的唯一所有權。此外,收益預計將支持公司的股票回購計劃。首席執行官兼董事會主席Robert Mattacchione對公司實現收購進展和承諾籌集非稀釋性資本的熱情表示。Novo Integrated Sciences通過多學科生態系統開創了一種全面醫療保健方法,計劃利用先進的醫療技術和康復科學來分散非災難性醫療服務。
2024年6月13日,Novo Integrated Sciences,Inc.宣佈收到了匯豐銀行發行的備用信用證(SBLC),將通過Swift MT760交付。該發展計劃是該公司先前申請的貨幣化計劃的一部分,預計在完成SBLC的貨幣化後可獲得約7800萬美元的總資金籌集收益。這些資金旨在促進Ophir Collection的收購,授予Novo Integrated Sciences收藏的唯一所有權。此外,收益預計將支持公司的股票回購計劃。首席執行官兼董事會主席Robert Mattacchione對公司實現收購進展和承諾籌集非稀釋性資本的熱情表示。Novo Integrated Sciences通過多學科生態系統開創了一種全面醫療保健方法,計劃利用先進的醫療技術和康復科學來分散非災難性醫療服務。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息